UMIN-CTR Clinical Trial

Unique ID issued by UMIN C000000249
Receipt number R000000314
Scientific Title A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205)
Date of disclosure of the study information 2006/09/01
Last modified on 2005/09/28 14:02:56

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205)

Acronym

Percutaneous trans-esophageal gastric tubing (JIVROSG-0205)

Scientific Title

A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205)

Scientific Title:Acronym

Percutaneous trans-esophageal gastric tubing (JIVROSG-0205)

Region

Japan


Condition

Condition

Malignant gastrointestinal obstruction

Classification by specialty

Hepato-biliary-pancreatic medicine Surgery in general Gastrointestinal surgery
Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Explanatory

Developmental phase

Phase II,III


Assessment

Primary outcomes

Improvement of subjective symptoms compared to previous nasal tubing.

Key secondary outcomes

Adverse events and feasibility of procedure


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Under local anesthesia and fluoroscopy or ultrasonic guidance, a percutaneous route to cervical esophagus is made by direct puncture to the intra-esophageal balloon inserted via nasal or oral route, and then, a drainage tube is placed from the neck surface to the stomach using this route.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) No expectation for removal of nasal tube caused by persistent and malignant gastro-intestinal obstruction.
2) No pathological condition around cervical esophagus.
3) Adequate cardiac, hepatic, renal, respiratory, and bone marrow functions.
4) Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 3.
5) Expected survival more than 4 weeks.
6) Written informed consent.

Key exclusion criteria

1) Tracheostomy.
2) Intestinal obstruction due to the lesions between transverse colon and rectum.
3) Pregnancy.
4) Local therapy for neck region

Target sample size

33


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takeshi Aramaki

Organization

Shizuoka Cancer Center

Division name

Department of Imaging Diagnosis

Zip code


Address

1007, Shimonagakubo, Nagaizumi-cho, Shuntoh-gun, Shizuoka 411-8777, Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Yasuaki Arai

Organization

JIVROSG, Coordinating Office

Division name

Division of Diagnostic Radiology, National Cancer Center Hospital

Zip code


Address

5-1-1,Tsukiji,Chuo-ku,Tokyo,104-0045,Japan

TEL

0335422511

Homepage URL

http://jiprosg.umin.jp/

Email

jvrosgffice@ml.res.ncc.go.jp


Sponsor or person

Institute

Japan Interventional Radiology in Oncology Study Group (JIVROSG)

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2006 Year 09 Month 01 Day


Related information

URL releasing protocol

http://jvrosg.umin.jp/

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2002 Year 11 Month 30 Day

Date of IRB


Anticipated trial start date

2003 Year 07 Month 01 Day

Last follow-up date

2006 Year 05 Month 01 Day

Date of closure to data entry

2006 Year 06 Month 01 Day

Date trial data considered complete

2006 Year 06 Month 01 Day

Date analysis concluded

2006 Year 09 Month 01 Day


Other

Other related information



Management information

Registered date

2005 Year 09 Month 28 Day

Last modified on

2005 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000314


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name